According to WiseGuy Reports, the Reserpine Market was valued at USD 1.57 billion in 2024 and is projected to reach USD 2.01 billion by 2032, expanding at a CAGR of 3.17% during the forecast period. The market is witnessing steady growth due to the rising prevalence of hypertension, increasing demand for antihypertensive medications, expanding healthcare infrastructure, and growing awareness...